User profiles for Cathy Zhang
Cathy T. ZhangSaint-Gobain Verified email at saint-gobain.com Cited by 953 |
[HTML][HTML] Fair allocation of scarce medical resources in the time of Covid-19
…, M Parker, A Glickman, C Zhang… - … England Journal of …, 2020 - Mass Medical Soc
Allocating Scarce Medical Resources for Covid-19 The Covid-19 pandemic has already
stressed health care systems throughout the world, requiring rationing of medical equipment …
stressed health care systems throughout the world, requiring rationing of medical equipment …
Small-molecule p21-activated kinase inhibitor PF-3758309 is a potent inhibitor of oncogenic signaling and tumor growth
…, J Piraino, JK Westwick, C Zhang… - Proceedings of the …, 2010 - National Acad Sciences
Despite abundant evidence that aberrant Rho-family GTPase activation contributes to most
steps of cancer initiation and progression, there is a dearth of inhibitors of their effectors (eg, …
steps of cancer initiation and progression, there is a dearth of inhibitors of their effectors (eg, …
Multifunctional ferrofluid-infused surfaces with reconfigurable multiscale topography
Developing adaptive materials with geometries that change in response to external stimuli
provides fundamental insights into the links between the physical forces involved and the …
provides fundamental insights into the links between the physical forces involved and the …
Liquid-induced topological transformations of cellular microstructures
The fundamental topology of cellular structures—the location, number and connectivity of
nodes and compartments—can profoundly affect their acoustic 1 , 2 , 3 – 4 , electrical 5 , …
nodes and compartments—can profoundly affect their acoustic 1 , 2 , 3 – 4 , electrical 5 , …
[PDF][PDF] Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitor
…, J Chionis, Q Zhang, K Eisele, C Liu, C Zhang… - Cancer cell, 2021 - cell.com
The CDK4/6 inhibitor, palbociclib (PAL), significantly improves progression-free survival in
HR + /HER2 − breast cancer when combined with anti-hormonals. We sought to discover PAL …
HR + /HER2 − breast cancer when combined with anti-hormonals. We sought to discover PAL …
Near‐infrared fluorescent sensors based on single‐walled carbon nanotubes for life sciences applications
AA Boghossian, J Zhang, PW Barone… - …, 2011 - Wiley Online Library
Many properties of single‐walled carbon nanotubes (SWCNTs) make them ideal candidates
for sensors, particularly for biological systems. Both their fluorescence in the near‐infrared …
for sensors, particularly for biological systems. Both their fluorescence in the near‐infrared …
PEST domain mutations in Notch receptors comprise an oncogenic driver segment in triple-negative breast cancer sensitive to a γ-secretase inhibitor
K Wang, Q Zhang, D Li, K Ching, C Zhang, X Zheng… - Clinical cancer …, 2015 - AACR
Purpose: To identify and characterize novel, activating mutations in Notch receptors in breast
cancer and to determine response to the gamma secretase inhibitor (GSI) PF-03084014. …
cancer and to determine response to the gamma secretase inhibitor (GSI) PF-03084014. …
Common variation in COL4A1/COL4A2 is associated with sporadic cerebral small vessel disease
…, MA Ikram, WT Longstreth, R Schmidt, CR Zhang… - Neurology, 2015 - AAN Enterprises
Objectives: We hypothesized that common variants in the collagen genes COL4A1/COL4A2
are associated with sporadic forms of cerebral small vessel disease. Methods: We …
are associated with sporadic forms of cerebral small vessel disease. Methods: We …
Discovery of PF-06873600, a CDK2/4/6 Inhibitor for the Treatment of Cancer
…, M Xu, L Zehnder, Q Zhang, C Zhang… - Journal of Medicinal …, 2021 - ACS Publications
Control of the cell cycle through selective pharmacological inhibition of CDK4/6 has proven
beneficial in the treatment of breast cancer. Extending this level of control to additional cell …
beneficial in the treatment of breast cancer. Extending this level of control to additional cell …
Novel tricyclic poly (ADP-ribose) polymerase-1 inhibitors with potent anticancer chemopotentiating activity: design, synthesis, and X-ray cocrystal structure
…, XH Yu, SE Zook, RA Kumpf, C Zhang… - Journal of medicinal …, 2002 - ACS Publications
A series of novel compounds have been designed that are potent inhibitors of poly(ADP-ribose)
polymerase-1 (PARP-1), and the activity and physical properties have been …
polymerase-1 (PARP-1), and the activity and physical properties have been …